| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
|
Rofo, Fadi
|
|
|
19 |
5 |
p. 1588-1602
|
artikel
|
| 2 |
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
|
Rofo, Fadi
|
|
|
19 |
5 |
p. 1588-1602
|
artikel
|
| 3 |
Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
|
Knecht, Luisa
|
|
|
19 |
5 |
p. 1489-1502
|
artikel
|
| 4 |
Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
|
Knecht, Luisa
|
|
|
19 |
5 |
p. 1489-1502
|
artikel
|
| 5 |
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
|
Benatar, Michael
|
|
|
19 |
5 |
p. 1686
|
artikel
|
| 6 |
Correction to: Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study
|
Benatar, Michael
|
|
|
19 |
5 |
p. 1686
|
artikel
|
| 7 |
Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury
|
Borgonetti, Vittoria
|
|
|
19 |
5 |
p. 1634-1648
|
artikel
|
| 8 |
Dual HDAC/BRD4 Inhibitors Relieves Neuropathic Pain by Attenuating Inflammatory Response in Microglia After Spared Nerve Injury
|
Borgonetti, Vittoria
|
|
|
19 |
5 |
p. 1634-1648
|
artikel
|
| 9 |
Expanding Indications for a Ketogenic Diet as an Adjuvant Therapy in Adult Refractory Status Epilepticus: an Exploratory Study Using Moderation Analysis
|
Koh, Seungyon
|
|
|
19 |
5 |
p. 1526-1534
|
artikel
|
| 10 |
Expanding Indications for a Ketogenic Diet as an Adjuvant Therapy in Adult Refractory Status Epilepticus: an Exploratory Study Using Moderation Analysis
|
Koh, Seungyon
|
|
|
19 |
5 |
p. 1526-1534
|
artikel
|
| 11 |
Impact of Multidomain Lifestyle Intervention on Cerebral Cortical Thickness and Serum Brain-Derived Neurotrophic Factor: the SUPERBRAIN Exploratory Sub-study
|
Moon, So Young
|
|
|
19 |
5 |
p. 1514-1525
|
artikel
|
| 12 |
Impact of Multidomain Lifestyle Intervention on Cerebral Cortical Thickness and Serum Brain-Derived Neurotrophic Factor: the SUPERBRAIN Exploratory Sub-study
|
Moon, So Young
|
|
|
19 |
5 |
p. 1514-1525
|
artikel
|
| 13 |
Inhibition of the RNA Regulator HuR by SRI-42127 Attenuates Neuropathic Pain After Nerve Injury Through Suppression of Neuroinflammatory Responses
|
Sorge, Robert E.
|
|
|
19 |
5 |
p. 1649-1661
|
artikel
|
| 14 |
Inhibition of the RNA Regulator HuR by SRI-42127 Attenuates Neuropathic Pain After Nerve Injury Through Suppression of Neuroinflammatory Responses
|
Sorge, Robert E.
|
|
|
19 |
5 |
p. 1649-1661
|
artikel
|
| 15 |
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
|
Zanghì, Aurora
|
|
|
19 |
5 |
p. 1535-1545
|
artikel
|
| 16 |
Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic
|
Zanghì, Aurora
|
|
|
19 |
5 |
p. 1535-1545
|
artikel
|
| 17 |
Neuroimaging Assessment of Pain
|
Luo, Jing
|
|
|
19 |
5 |
p. 1467-1488
|
artikel
|
| 18 |
Neuroimaging Assessment of Pain
|
Luo, Jing
|
|
|
19 |
5 |
p. 1467-1488
|
artikel
|
| 19 |
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
|
Uzungil, Volkan
|
|
|
19 |
5 |
p. 1662-1685
|
artikel
|
| 20 |
Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression
|
Uzungil, Volkan
|
|
|
19 |
5 |
p. 1662-1685
|
artikel
|
| 21 |
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model
|
Estévez-Silva, Héctor M.
|
|
|
19 |
5 |
p. 1566-1587
|
artikel
|
| 22 |
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer's Disease APP/PS1 Mouse Model
|
Estévez-Silva, Héctor M.
|
|
|
19 |
5 |
p. 1566-1587
|
artikel
|
| 23 |
P2R Inhibitors Prevent Antibody-Mediated Complement Activation in an Animal Model of Neuromyelitis Optica
|
Kalluri, Sudhakar Reddy
|
|
|
19 |
5 |
p. 1603-1616
|
artikel
|
| 24 |
P2R Inhibitors Prevent Antibody-Mediated Complement Activation in an Animal Model of Neuromyelitis Optica
|
Kalluri, Sudhakar Reddy
|
|
|
19 |
5 |
p. 1603-1616
|
artikel
|
| 25 |
Quantifying Patient Investment in Novel Neurological Drug Development
|
MacPherson, Amanda
|
|
|
19 |
5 |
p. 1507-1513
|
artikel
|
| 26 |
Quantifying Patient Investment in Novel Neurological Drug Development
|
MacPherson, Amanda
|
|
|
19 |
5 |
p. 1507-1513
|
artikel
|
| 27 |
Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
|
Abdallah, Mahmoud S.
|
|
|
19 |
5 |
p. 1687
|
artikel
|
| 28 |
Retraction Note: The Antidiabetic Metformin as an Adjunct to Antidepressants in Patients with Major Depressive Disorder: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial
|
Abdallah, Mahmoud S.
|
|
|
19 |
5 |
p. 1687
|
artikel
|
| 29 |
Synthetic PPAR Agonist DTMB Alleviates Alzheimer’s Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
|
Oh, Eunji
|
|
|
19 |
5 |
p. 1546-1565
|
artikel
|
| 30 |
Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
|
Oh, Eunji
|
|
|
19 |
5 |
p. 1546-1565
|
artikel
|
| 31 |
The Human Cost: Patient Contribution to Clinical Trials in Neurology
|
Reoma, Lauren B.
|
|
|
19 |
5 |
p. 1503-1506
|
artikel
|
| 32 |
The Human Cost: Patient Contribution to Clinical Trials in Neurology
|
Reoma, Lauren B.
|
|
|
19 |
5 |
p. 1503-1506
|
artikel
|
| 33 |
Therapeutic Approaches to the Neurologic Manifestations of COVID-19
|
Graham, Edith L.
|
|
|
19 |
5 |
p. 1435-1466
|
artikel
|
| 34 |
Therapeutic Approaches to the Neurologic Manifestations of COVID-19
|
Graham, Edith L.
|
|
|
19 |
5 |
p. 1435-1466
|
artikel
|
| 35 |
Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis
|
Edo, Ángel
|
|
|
19 |
5 |
p. 1617-1633
|
artikel
|
| 36 |
Therapeutic Effect of IL-21 Blockage by Gene Therapy in Experimental Autoimmune Encephalomyelitis
|
Edo, Ángel
|
|
|
19 |
5 |
p. 1617-1633
|
artikel
|
Tijdschrift beschrijving